Urapidil hydrochloride injection and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHIJIAZHUANG NO 4 PHARMA
- Publication Date
- 2022-01-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of pharmaceutical preparations, in particular to urapidil hydrochloride injection and a preparation method thereof. Background technique
[0002] Urapidil hydrochloride is a uracil derivative substituted by phenylpiperazine. It is currently an effective and safe vasodilator for the treatment of hypertensive crisis, severe hypertension, control of hypertension during surgery, and treatment of congestive heart failure. It is a national essential drug. In addition, urapidil hydrochloride generally does not cause reflex tachycardia while lowering blood pressure.
[0003] At present, the pharmaceutical preparations mainly include injections, freeze-dried powder injections, tablets, capsules, etc. Among them, tablets and capsules are all oral preparations, and the drug efficacy is reduced due to the unavoidable first-pass effect; freeze-dried powder injections need to be reconstituted after reconstitution. Reuse ...